Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

10-K

SEC Filing Details

Document Details

Form
Filing Date
Apr 1, 2013
Document Date
Dec 31, 2012
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Stemline Therapeutics
Issuer
STEMLINE THERAPEUTICS INC

Filing Formats



Copyright 2017 - Stemline Therapeutics, Inc. All rights reserved